Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.
Free White Paper
As a guest to ChinaBio® Today, you have access to summaries of over 2500 articles including our archives. You can use the Search feature on the left menu bar to find what you're looking for, or you can browse summaries of our articles by the categories listed under Subscriber Articles. You can access any article that is marked as FREE. Or you can subscribe and have access to our entire content.
3SBio Sets Target of $712 Million for Hong Kong IPO | May 27, 2015
BeiGene Raises $97 Million to Develop Cancer Drug Portfolio | May 13, 2015
WuXi PharmaTech Receives $3.2 Billion Privatization Offer | April 30, 2015>> See all top stories...
Shenzhen Hepalink Pharma Enters $441 Million Deal for Resverlogix CV Drug | April 27, 2015
ChinaBio® in the News